bicalutamide has been researched along with methylselenic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, H; Dong, Y; Duplessis, T; Ge, Y; Horikawa, I; Ip, C; Liu, S; Lustig, AJ; Qi, Y; Rennie, PS; Rowan, BG; Yu, Q; Zhang, H | 1 |
1 other study(ies) available for bicalutamide and methylselenic acid
Article | Year |
---|---|
Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Synergism; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA Stability; RNA, Messenger; Telomerase; Tosyl Compounds | 2010 |